StockData
Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc (CPIX) income statement

CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$5.80+0.59 (+11.32%)

Close on Nov 17, 2026Market cap $86.90MP/E –Yield –

Cumberland Pharmaceuticals Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
121.1%
Operating margin
-30.8%
Net margin
-34.9%
Return on equity, FY2025
-11.9%

Financial strength

Current ratio
0.96
Debt to equity
–
Debt to assets
–
Cash to current liabilities
11.0%

Valuation

P/E ratio
–
Price to sales
2.78
Price to book
4.98
Dividend yield
–

See a number that looks wrong?